Description
PRINCIPIO ACTIVO: BACLOFENO
MYRBETRIC® contiene mirabegrón
RUXIENCE® 100 mg es un medicamento de uso intravenoso que contiene Rituximab
aumentando la producción de GMPc
NIMARIL 300MG/50ML SOL INY F.A. DERMOCOSMETICOS PRINCIPIO ACTIVO: BACLOFENOCaja C 1 Solucin Inyectable.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
